Angiotensin receptors in myometrium and myometrial vessels from uteri of women during the follicular and luteal phases of the menstrual cycle and in late pregnancy

Clinical Science

Volumn 90, Issue 6, 1996, Pages 499-505

  Bing, C ^a   Johnson, I R ^a   Broughton Pipkin, F ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Angiotensin receptors; Human; Menstrual cycle; Myometrium; Pregnancy

Indexed keywords

1 (4 AMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDROIMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; LOSARTAN; PROSTACYCLIN;

ADULT; ARTICLE; DISSOCIATION CONSTANT; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN TISSUE; LUTEAL PHASE; MENSTRUAL CYCLE; MYOMETRIUM; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; UTERUS; UTERUS GROWTH;

EID: 0030011165     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0900499     Document Type: Article

References (34)

1. Warren AY, Craven DJ, Symonds EM. Production of active and inactive renin by cultured explants from the human female genital tract. Br J Obstet Gynaecol 1982; 89: 628-32.
2. Johnson IR. Renin substrate, active and acid-activatable renin concentrations in human plasma and endometrium during the normal menstrual cycle. Br J Obstet Gynaecol 1980; 87: 875-82.
3. Maigaard S, Forman A, Andersson K-E. Differential effects of angiotensin, vasopressin and oxytocin on various smooth muscle tissues within the human uteroplacental unit. Acta Physiol Scand 1986; 128: 23-31.
4. Odum CU, Broughton Pipkin F. Studies on the effects of nitrendipine on oxytocin, angiotensin II and ergometrine-induced contraction of pregnant human myometrium in vitro. Br J Obstet Gynaecol 1988; 95: 765-70.
5. Bottari SP, de Gasparo M, Steckelings UM, Levens NR. Angiotensin II receptor subtypes: characterization, signalling mechanisms and possible physiological implications. Frontiers Neuroendocrinol 1993; 14: 123-71.
6. Whitebread S, Mele M, Kamber B, de Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989; 163: 284-91
7. Lazard D, Villageois P, Briend-Sutren MM, et al. Characterization of a membrane glycoprotein having pharmacological and biochemical properties of an AT2 angiotensin II receptor from human myometrium. Eur J Biochem 1994; 220: 919-26.
8. de Gasparo M, Whitebread S, Kalenga MM, de Hertogh R, Crevoisier P, Thomas K. Down regulation of the angiotensin II receptor subtype AT2 in human myometrium during pregnancy. Regul Pept 1994; 53: 39-45.
9. Kambayashi Y, Bardhan S, Takahashi K, et al. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 1993; 268: 24,543-6.
10. Burnier M, Centeno G, Grouzmann E, Walker P, Waeber B, Brunner HR. In vitro effects of DuP 753, a nonpeptide angiotensin II recepor antagonist, on human platelets and rat vascular smooth muscle cells. Am J Hypertens 1991; 4: 438-43.
11. Baker PN, Broughton Pipkin F, Symonds EM. Changes in platelet angiotensin II binding sites associated with the human menstrual cycle. Am J Obstet Gynecol 1990; 163: 175-76.
12. Baker PN, Broughton Pipkin F, Symonds EM. Changes in human platelet angiotensin II binding sites associated with early pregnancy. Am J Obstet Gynecol 1992; 166: 255-6.
13. Baker PN, Broughton Pipkin F, Symonds EM. A comparative study of platelet angiotensin II binding and the angiotensin II sensitivity test as predictors of pregnancy-induced hypertension. Clin Sci 1992; 83: 89-95.
14. Bing C, Broughton Pipkin F. Uterine angiotensin II receptors in non-pregnant and pregnant women. J Physiol 1993; 467: 293P.
15. McQueen J, Kingdom JP, Jardine AG, Connell JMC, Whittle MJ. Vascular angiotensin II and atrial natriuretic peptide receptors in normal and growth-retarded human placentae. J Endocrinol 1990; 126: 341-7.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
17. Johnson J, Johnson IR, Ronan JE, Craven DJ, The site of renin in the human uterus. Histopathology 1964; 8: 273-8.
18. Chevillotte E, Rouzaire-Dubois B, Devynck MA, Meyer P. Variations in the number of uterine angiotensin receptors following changes in plasma angiotensin levels. Contr Nephrol 1976; 3: 134-41.
19. Gunther S, Gimbrone MA, Alexander RW. Regulation by angiotensin II of its receptors in resistance blood vessels. Nature (London) 1980; 187: 230-2.
20. Tsutsumi K, Saavedra JM. Characterization of AT2 angiotensin II receptors in rat anterior cerebral arteries. Am J Physiol 1991; 261: H667-70.
21. Naveri L, Stromberg C, Saavedra JM. Angiotensin II AT2 receptor stimulation extends the upper limit of cerebral blood flow autoregulation: agonist effects of CGP 42112 and PD 123319. J Cereb Blood Flow Metab 1994; 14: 38-44.
22. Schirar A, Capponi A, Catt KJ. Regulation of uterine angiotensin II receptors by oestrogen and progesterone. Endocrinology (Baltimore) 1960; 106: 5-12.
23. Robertson JIS, Weir RJ, Dusterdieck GO, Fraser R, Tree M. Renin, angiotensin and aldosterone in human pregnancy and the menstrual cycle. Scot Med J 1971; 16: 183-96.
24. Moore TJ, Taylor T, Williams GH. Human platelet angiotensin II receptors: regulation by the circulating angiotensin level. J Clin Endocrinol Metab 1984; 58: 778-82.
25. Sasamura H, Dzau VJ, Pratt RE. Densensitization of angiotensin receptor function. Kidney Int 1994; 46: 1499-501.
26. Siddiqi TA, Koenig BB, Clark KE. Pregnancy causes a decrease in the number and affinity of myometrial angiotensin II receptors. Obstet Gynecol 1986; 68: 820-4.
27. Cox BE, Ipson MA, Shaul PW, Kamm KE, Rosenfeld CR. Myometrial angiotensin II receptor subtypes change during ovine pregnancy. J Clin Invest 1993; 91: 2240-8.
28. Magness RR, Osei-Boaten K, Mitchell MD, Rosenfeld CR. In vitro prostacyclin production by ovine uterine and systemic arteries: effects of angiotensin II. J Clin Invest 1985; 76: 2206-12.
29. Ipson MA, Rosenfeld CR, Magness RR, Kamm KE. Relationship between myometrial (MYO) contractile responses to angiotensin II (All) and changes in angiotensin II receptor subtypes in ovine pregnancy. Proc Soc Gynecol Invest (Toronto) 1993; 312.
30. Quaas L, Zahradnik HP, Breckwoldt M. Age-, cycle- and topographic dependency of human myometrial prostaglandin (6-keto-PGFIα, PGF2α)-synthesis in vitro. Prostaglandins 1985; 29: 739-45.
31. Fitzgerald DJ, Entman SS, Mulloy K, Fitzgerald GA. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation 1987; 75: 956-47.
32. Dzau VJ, Sasamura H, Hein L. Heterogeneity of angiotensin synthetic pathways and receptor subtypes; physiological and pharmacological implications. J Hypertens 1993; II (Suppl. 3): S13-8.
33. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995; 95: 651-7.
34. Kambayashi Y, Bardhan S, Inagami T. Peptide growth factors markedly decrease the ligand binding of angiotensin II type 2 receptors in rat cultured vascular smooth muscle cells. Biochem Biophys Res Commun 1993; 194: 478-82.